Stifel Financial Corp
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Stifel Financial Corp. operates as a full-service financial services holding company headquartered in St. Louis, Missouri, providing a comprehensive range of products and services through its subsidiaries. Its core offerings include securities brokerage; investment banking with mergers and acquisitions, public offerings, and private placements; equity and fixed income sales, trading, and research; wealth management for individual investors, professional money managers, businesses, and municipalities; and consumer and commercial lending through Stifel Bank & Trust. The company serves clients across the United States, Europe, the Middle East, and Asia with more than 400 offices and approximately 10,000 professionals. Founded in 1890, Stifel operates mainly through three segments: Global Wealth Management, Institutional Group, and Other. Recent major changes include the acquisition of Bryan, Garnier & Co., a European investment bank specializing in healthcare and technology sectors, which significantly expands Stifel's advisory footprint in Europe. Additionally, Stifel launched Stifel Discover, a personalized content feed within its Wealth Tracker app, enhancing client engagement through tailored financial insights. The company is also completing an asset acquisition from Spring Mountain Capital involving over $1 billion in assets under management to strengthen its alternative asset management capabilities. Stifel continues to grow both organically and through strategic acquisitions, maintaining its position as a leading brokerage and investment banking firm with robust equity research and wealth management offerings.
Company News
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
Stifel Makes Strategic Investment in Meow; Partners to Launch Next-Generation Digital Banking Platform
Stifel Financial Schedules Third Quarter Financial Results Conference Call
Morgan Stanley Direct Lending Fund (NYSE:MSDL) vs. Stifel Financial (NYSE:SF) Financial Contrast
Faron Pharmaceuticals keeps Stifel backing ahead of BEXERA test
199,915 Shares in Stifel Financial Corporation $SF Acquired by Argent Capital Management LLC
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
Stifel Financial: Mid-Market Advisory And Commissions Could Resist Hikes
1919 Investment Counsel Recognized Among Barron's 2026 Top 100 RIA Firms
Santhera first-half sales double as Stifel keeps ‘buy' rating and CHF25 target
Stifel Reports August 2026 Operating Data
Stifel Expands Venture Banking Presence Across East Coast With Senior Hires
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $698,000 Position in Stifel Financial Corporation $SF
Amundi Cuts Stock Position in Stifel Financial Corporation $SF
KBW Announces Index Rebalancing for Third-Quarter 2026
Mission Group gets Stifel 'buy' as recovery outpaces valuation
Stifel Deepens Fixed Income Platform with Senior Talent
Canada Pension Plan Investment Board Purchases Shares of 93,950 Stifel Financial Corporation $SF
Stifel Reports July 2026 Operating Data
Stifel reiterates Buy on Faron Pharmaceuticals after cash update secures runway to key trial readout